Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PMatX Innovation Lab was an Israel-based open innovation lab and incubator focused on next-generation electronics, advanced materials, and novel manufacturing methods rather than therapeutics. The lab operated in Yavne, Israel, adjacent to Merck's R&D site, and was run by M Ventures with support from Merck, Flex, and the Israel Innovation Authority. PMatX supported early-stage startups developing technologies such as printed electronics, sensing systems, computational imaging, and selected device-oriented healthcare applications. Available public information indicates it functioned as a corporate-backed incubation platform rather than a standalone drug-development biotech company. Because the entity appears to have been an incubator program with a time-limited budget and only older public references, it does not appear to be an active standalone healthcare company today.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PMatX Innovation Lab.